Skip to main content
Atencion Primaria logoLink to Atencion Primaria
letter
. 2008 Dec 10;35(9):495–496. [Article in Spanish] doi: 10.1157/13075482

Metanfetamina

Y Álvarez a,b, A Cabrero a,c, S Abanades a,b, M Farré a,b
PMCID: PMC7668887  PMID: 15919028

The content is available as a PDF (72.9 KB).

Bibliografía

  • 1.Royo-Isach J., Magrané M., Velilla A., Ruiz L. Consumidores de «speed» (metanfetamina): un viaje de ida y vuelta entre el «éxtasis» (MDMA) y la cocaína. Algunos aspectos clínicos, preventivos y asistenciales. Aten Primaria. 2004;34:553–556. doi: 10.1016/S0212-6567(04)70862-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Karch S.B. 2nd ed. CRC Press; Boca Raton: 1996. The pathology of drug abuse. p.199-230. [Google Scholar]
  • 3.McCann U.D., Ricaurte G.A. Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci BiobehavRev. 2004;27:821–826. doi: 10.1016/j.neubiorev.2003.11.003. [DOI] [PubMed] [Google Scholar]
  • 4.Wang G.J., Volkow N.D., Chang L., Miller E., Sedler M., Hitzemann R. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry. 2004;161:242–248. doi: 10.1176/appi.ajp.161.2.242. [DOI] [PubMed] [Google Scholar]
  • 5.Harris D.S., Boxenbaum H., Everhart E.T., Sequeira G., Mendelson J.E., Jones R.T. The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther. 2003;74:475–486. doi: 10.1016/j.clpt.2003.08.002. [DOI] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES